Wire
ALX Oncology Names Jeff Knight Chief Development, Operating Officer
ALX Oncology (ALXO) said Monday it named Jeff Knight as chief development and operating officer, effective immediately.The company said Knight most recently served in the same role at Crinetics Pharmaceuticals (CRNX).Shares of ALX were up over 8% in Monday trading.Price: $1.88, Change: $+0.18, Percent Change: +10.59%
$ALXO$CRNX
